Abrams P, Cardozo L, Fall M The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002; 187:(1)116-126

Al Dandan HB, Coote S, McClurg D. Prevalence of lower urinary tract symptoms in people with multiple sclerosis. Int J MS Care. 2020; 22:(2)91-99

Multiple sclerosis diagnosis and management: a simple literature review. 2019. (accessed 14 June 2021)

Bladder and Bowel Community. Multiple sclerosis and incontinence. 2021. (accessed 24 June 2021)

Johns Hopkins University. Multiple sclerosis (MS). 2021. (accessed 14 June 2021)

Johns JS, Krogh K, Ethans K, Chi J, Queree M, Eng JJ Pharmacological management of neurogenic bowel dysfunction after spinal cord injury and multiple sclerosis: a systematic review and clinical implications. J Clin Med. 2021; 10:(4)

Lakin L, Davis BE, Binns CC, Currie KM, Rensel MR. Comprehensive approach to management of multiple sclerosis: addressing invisible symptoms—a narrative review. Neurol Ther. 2021; 0:(1)75-98

Lin SD, Butler JE, Boswell-Ruys CL The frequency of bowel and bladder problems in multiple sclerosis and its relation to fatigue: a single centre experience. PLoS ONE. 2019; 14:(9)

Multiple Sclerosis International Federation. MS in Focus. Bladder and Bowel. 2014. (accessed 11 June 2021)

Multiple Sclerosis Limited. Symptoms. Continence care including bladder and bowel dysfunction. 2021. (accessed 11 June 2021)

MS Trust. Prevalence and incidence of multiple sclerosis. Prevalence and incidence of multiple sclerosis. 2020. (accessed 11 June 2021)

Public Health England. Multiple sclerosis: prevalence, incidence and smoking status—data briefing. 2020. http://com (accessed 11 June 2021)

Royal College of Nursing. Bowel care. Management of lower bowel dysfunction, including digital rectal examination and digital removal of faeces. 2019. (accessed 11 June 2021)

Yates A. Transanal irrigation: an alternative therapy for bowel dysfunction?. Br J Nurs. 2019; 28:(7)426-428

Continence issues in individuals living with multiple sclerosis

24 June 2021
6 min read
Volume 30 · Issue 12

Multiple sclerosis (MS) is a chronic, progressive neurological disease of the central nervous system, which appears to have both inflammatory and degenerative components (Johns Hopkins University, 2021). It is characterised by areas of demyelination (or damage to the coating around nerve fibres) and the formation of plaques along the nerve pathways (Johns Hopkins University, 2021). It may be triggered by either environmental factors or appear in genetically susceptible individuals, and is associated with severe side effects and disabling symptoms (Alshammari et al, 2019).

There are several types of MS, including relapsing and remitting (relapses of symptoms with periods of partial or complete remission), primary progressive (symptoms gradually get worse), secondary progressive (sustained build-up of disability), and progressive relapsing (Alshammari et al, 2019). All are life-changing forms of the disease that affect about 2.5 million people globally, with its incidence on the increase (Lin et al, 2019).

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content